FDA Inspection 1089146 — Bloodworks

Bloodworks — FEI 3020842

The FDA completed an inspection of Bloodworks on May 10, 2019 in Bellevue, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 10, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bellevue, WA (United States)

Citations

IDCFRDescription
1811421 CFR 630.30(a)(1)Donor deferral

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.